Sustained Short-Selling Activity
Krystal Biotech (KRYS) continues to be a target for short sellers, appearing on the FINRA threshold list for 77 consecutive trading days. This sustained pressure indicates that the stock has consistently seen high levels of short-selling volume, keeping it on the radar for market analysts tracking bearish trends.
Market Data
With 13.7% of its float shorted and a borrow fee of 0.3%, KRYS is seeing significant institutional interest. The stock's long-term presence on the threshold list suggests that short sellers are not easily deterred, maintaining their positions despite the stock's price movements. Investors should monitor the stock for any changes in borrow availability or sudden spikes in short volume that could indicate an escalation in bearish sentiment.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.